Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-17 4:16 pm Sale | 13D | VBI VACCINES INC CDA COM VBIV | PERCEPTIVE ADVISORS LLC | 1,261,710 4.4% | -119,645 (-8.66%) | View |
| 2024-04-17 4:15 pm Purchase | 13D | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 5,143,575 8.3% | 1,874,996 (+57.36%) | View |
| 2024-04-15 4:20 pm Purchase | 13G | Contineum Therapeutics Inc. CTNM | PERCEPTIVE ADVISORS LLC | 1,566,669 8.5% | 1,566,669 (New Position) | View |
| 2024-04-15 08:21 am Purchase | 13G | ACRIVON THERAPEUTICS INC ACRV | PERCEPTIVE ADVISORS LLC | 5,360,858 17.4% | 2,353,000 (+78.23%) | View |
| 2024-04-10 4:50 pm Purchase | 13D | LANDOS BIOPHARMA INC LABP | PERCEPTIVE ADVISORS LLC | 1,486,991 47.7% | 1,486,991 (New Position) | View |
| 2024-04-03 6:18 pm Unchanged | 13D | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 3,268,579 5.4% | 0 (Unchanged) | View |
| 2024-03-20 5:51 pm Purchase | 13D | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 3,268,579 5.4% | 8,566 (+0.26%) | View |
| 2024-03-14 4:13 pm Purchase | 13G | PRECISION BIOSCIENCES INC DTIL | PERCEPTIVE ADVISORS LLC | 500,000 7.9% | 500,000 (New Position) | View |
| 2024-03-11 5:45 pm Purchase | 13G | CRYOLIFE INC. CRY | PERCEPTIVE ADVISORS LLC | 2,383,978 5.8% | 2,383,978 (New Position) | View |
| 2024-03-06 4:15 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | PERCEPTIVE ADVISORS LLC | 0 0% | -2,099,952 (Position Closed) | View |
| 2024-03-01 8:05 pm Sale | 13D | CRINETICS PHARMACEUTICALS INC CRNX | PERCEPTIVE ADVISORS LLC | 1,488,703 1.9% | -3,844,829 (-72.09%) | View |
| 2024-03-01 7:09 pm Purchase | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | PERCEPTIVE ADVISORS LLC | 19,221,743 6.9% | 7,242,328 (+60.46%) | View |
| 2024-02-29 7:45 pm Purchase | 13D | LIANBIO SPONSORED ADS LIAN | PERCEPTIVE ADVISORS LLC | 57,850,841 53.4% | 1,530,881 (+2.72%) | View |
| 2024-02-23 4:16 pm Unchanged | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 1,394,716 9.9% | 0 (Unchanged) | View |
| 2024-02-14 5:14 pm Sale | 13G | RAIN ONCOLOGY INC. RAIN | PERCEPTIVE ADVISORS LLC | 0 0% | -2,483,619 (Position Closed) | View |
| 2024-02-14 4:56 pm Purchase | 13G | FORTE BIOSCIENCES FBRX | PERCEPTIVE ADVISORS LLC | 3,633,635 9.9% | 5,860 (+0.16%) | View |
| 2024-02-14 4:52 pm Unchanged | 13G | APPLIED THERAPEUTICS INC APLT | PERCEPTIVE ADVISORS LLC | 4,580,249 5.9% | 0 (Unchanged) | View |
| 2024-02-14 4:52 pm Unchanged | 13G | ALDEYRA THERAPEUTICS, INC ALDX | PERCEPTIVE ADVISORS LLC | 8,593,586 14.6% | 0 (Unchanged) | View |
| 2024-02-14 4:51 pm Purchase | 13G | INHIBRX INC INBX | PERCEPTIVE ADVISORS LLC | 4,776,306 9.9% | 1,462,523 (+44.13%) | View |
| 2024-02-14 4:50 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | PERCEPTIVE ADVISORS LLC | 0 0% | -930,000 (Position Closed) | View |